Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 21Neoplasms 5Neoplasm Metastasis 3Advanced Malignant Solid Tumors 3Lung Neoplasms 2HER2+ Metastatic Breast Cancer (MBC) 1HER2 Positive Breast Carcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

neratinib 1Geriatric Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HER2 Positive Breast Carcinoma × neratinib × Clear all
NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

City of Hope Medical Center

Phase 2 Completed
25 enrolled 18 charts
Breast

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡